MD107C2 - Sistem transdermal terapeutic - Google Patents

Sistem transdermal terapeutic

Info

Publication number
MD107C2
MD107C2 MD94-0095A MD940095A MD107C2 MD 107 C2 MD107 C2 MD 107C2 MD 940095 A MD940095 A MD 940095A MD 107 C2 MD107 C2 MD 107C2
Authority
MD
Moldova
Prior art keywords
physostigmine
weight
layer
base
reservoir layer
Prior art date
Application number
MD94-0095A
Other languages
English (en)
Russian (ru)
Other versions
MD107B1 (ro
Inventor
Hille Thomas
Hoffmann Hans-Rainer
Knoch Axel
Huber Hans-Joachim
Schneider Gerhard
Stanislaus Fritz
Original Assignee
Klinge Pharma Gmbh
Lts Lohmann Therapie-Systeme Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3843239A external-priority patent/DE3843239C1/de
Application filed by Klinge Pharma Gmbh, Lts Lohmann Therapie-Systeme Gmbh & Co.Kg filed Critical Klinge Pharma Gmbh
Publication of MD107B1 publication Critical patent/MD107B1/ro
Publication of MD107C2 publication Critical patent/MD107C2/ro

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Invenţia se referă la medicină, în particular la sistemul transdermal terapeutic care conţine fizostigmină în calitate de parte componentă activă. Scopul invenţiei constă în mărirea timpului degajării de control a fizostigminei şi sporirea stabilităţii celei din urmă la păstrarea sistemului.Sistemul este constituit din stratul tegumentar impenetrabil pentru substanţa activă, stratul lipicios rezervarant şi în caz de necesitate din stratul de protecţie de desprindere. Totodată stratul rezervaravt conţine 67-90% de masă a materialului polimer din grupa copolimerilor-bloc pe baza stirenului şi 1,3-dienului, poliizobutilenilor, polimerilor pe baza acrilatului şi/sau metacrilatului şi esterilor colofoniului hidiogenizat, precum şi 10-25% de masă a plastifiantului pe baza hidraţilor de carbon şi/sau esterilor şi 6,3 - 11,7% de masă a fizostigminei.
MD94-0095A 1988-12-22 1994-04-28 Sistem transdermal terapeutic MD107C2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3843239A DE3843239C1 (ro) 1988-12-22 1988-12-22
SU894742793A RU2011384C1 (ru) 1988-12-22 1989-12-21 Трансдермальная терапевтическая система

Publications (2)

Publication Number Publication Date
MD107B1 MD107B1 (ro) 1994-12-31
MD107C2 true MD107C2 (ro) 1995-07-31

Family

ID=25875486

Family Applications (1)

Application Number Title Priority Date Filing Date
MD94-0095A MD107C2 (ro) 1988-12-22 1994-04-28 Sistem transdermal terapeutic

Country Status (2)

Country Link
LV (1) LV5578A3 (ro)
MD (1) MD107C2 (ro)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Cererea nr. 3606892, DE, A 61 K 31/465, A 61 K 31/44, 1988. *

Also Published As

Publication number Publication date
MD107B1 (ro) 1994-12-31
LV5578A3 (lv) 1994-05-10

Similar Documents

Publication Publication Date Title
AU743229C (en) Transdermal therapeutic system containing pergolide
EP0421454A3 (en) Dressing containing estrogen
MX9707732A (es) Compuestos triciclicos utiles en el tratamiento de desordenes proliferativos de celulas.
CA2034934A1 (en) Transdermal Therapeutic System Comprising Tulobuterol as Active Substance
MY100066A (en) Multicompartmentalized dermal and transdermal patches.
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
WO1999012529A3 (de) Transdermales therapeutisches system mit haftklebender reservoirschicht und unidirektional elastischer rückschicht
DE69430440T2 (de) Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten
YU47076B (sh) Postupak za izradu transdermalnog terapijskog sistema sa fizostigminom kao aktivnim sastojkom
YU47077B (sh) Postupak za izradu transdermalnog terapijskog sistema sa fizostigminom kao aktivnim sastojkom
BG102322A (en) Transdermal matrix system
IL95875A0 (en) Illudin analogs,pharmaceutical compositions containing the same and methods for the use thereof
MD107C2 (ro) Sistem transdermal terapeutic
DK0737475T3 (da) Anvendelse af en muscarin antagonist til fremstilling af et medikament til behandling og regulering af okular udvikling
CA2137961A1 (en) Cyclic depsipeptides having 18 ring atoms, and their use for combating endoparasites
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
MX9804137A (es) Metodos para determinar compuestos capaces de inhibir las actividades del oncogeno ha-ras.

Legal Events

Date Code Title Description
FG4A Patent for invention issued
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20090427